Company / Shares Outstanding
Enliven Therapeutics, Inc. Shares Outstanding History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
47.1M
FY2024
5-year range
3.1M / 47.1M
FY2020-FY2024
Trend
+32.4%
vs FY2023
Sector context
#175 of 212
Health Care
What the data says
Enliven Therapeutics, Inc.'s shares outstanding of 47072532.00 is lower than 83% of companies in the Health Care sector (FY2024). Increased from 3124274.00 to 47072532.00 over the past 2 years.
Based on SEC 10-K filings.
47072532.00 in FY2024 with a 5-year CAGR of +131.9%.
Increased from 3124274.00 to 47072532.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +29.5%
- 5-Year CAGR
- +131.9%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 212This company 47.1M Sector average 306.0M
▼
-84.6% below sector average
Key checks
Key Insights
- In FY2024, shares outstanding increased 32.4% year-over-year.
- Ranks #175 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.84 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 47.1M | +32.4% |
| FY2023 | 35.5M | +1037.7% |
| FY2022 | 3.1M | -85.6% |
| FY2021 | 21.7M | +55.6% |
| FY2020 | 13.9M | +1882.3% |
| FY2019 | 702.5K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026